Press Releases

EUGENE, Ore.--(BUSINESS WIRE)-- Arcimoto, Inc.® (NASDAQ: FUV) — makers of the Fun Utility Vehicle® (FUV) — an affordable, joyful, pure electric vehicle for everyday drivers and fleets, will release financial results for the third quarter ended September 30, 2018, after market close on Tuesday, November 13, 2018. Management will host an investor webcast at 1:30 p.m. PST (4:30 p.m.

TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX: ASP) (“Acerus” or the “Company”) today announced the signing of an amendment to its existing licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate mbH (“medac”), expanding the German pharmaceutical company’s exclusive right to market NATESTO® in the tota

WASHINGTON--(BUSINESS WIRE)-- Urban legends and Halloween go hand-in-hand. Generally defined by Merriam-Webster as widely circulated stories based on hearsay, urban legends often center on scary tales, but not always. A few have developed around the

PORTLAND, Maine--(BUSINESS WIRE)-- WEX Inc. (NYSE:WEX), an industry-leading global provider of corporate payments solutions, today announced a new partnership with JCB, Japan's premier and only international payment brand, to expand WEX virtual payments technology into Japan. The agreement makes WEX JCB’s first issuer of virtual cards and enables new functionality on the JCB network. The program is expect

SPRINGFIELD, Va.--(BUSINESS WIRE)-- Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, announced that

LONDON--(BUSINESS WIRE)-- Infiniti Research, a world-renowned market intelligence solutions provider, has announced the completion of their latest article on the benefits of a market intelligence report for manufacturing companies. This press release features multimedia. View the full release here: https://www.b

DALLAS--(BUSINESS WIRE)-- Crossplane Capital, a Dallas-based private equity firm that targets control investments in niche manufacturing, value-added distribution and industrial business services companies with up to $200 million of revenue, today announced its formal launch. With eight decades of combined experience transforming industrial companies as senior executives, operational improvement consultants, st

HOUSTON--(BUSINESS WIRE)-- The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP) declared today a distribution of $0.4207 per unit, representing a 2.9% increase from the second quarter 2018 distribution. This is the seventeenth quarterly distribution announced by the Partnership since its successful Initial Public Offeri

MINNEAPOLIS--(BUSINESS WIRE)-- Tennant Company (NYSE: TNC) will provide an overview of the company, including its strategies for growth, at Baird’s 48th Annual Global Industrial Conference in Chicago. Tom Paulson, Tennant’s Senior Vice President and CFO, is scheduled to present on Wednesday, November 7, at 11:00 am CST. Tennant’s presentation (and accompanying slides) wil

BASINGSTOKE, England--(BUSINESS WIRE)-- A new report from Juniper Research

TOKYO--(BUSINESS WIRE)-- Renesas Electronics Corporation (TSE:6723, “Renesas”), a premier supplier of advanced semiconductor solutions, today reported the financial results for the third quarter ended September 30, 2018 (July 1, 2018 to September 30, 2018). “Our third quarter non-GAAP semiconductor sales decreased by 8.7% year-on-year, and our efforts to restrain our production volu

OSAKA, Japan--(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue +4.2%, led by Growth Drivers, with growth in every region Underlying Revenue was solid at +4.2%, with continued strong momentum from Takeda's Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets), which grew +9.8%.

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)-- AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, announced that it filed today with the ASX its Appendix 4C - Quarterly Cash Flow Report for the quarter ended 30 September 2018. Provided below is an update on the substantial accomplishments achieved during the first fiscal quarter, including the September 2018 approval

SAN FRANCISCO--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of

LAUSANNE, Switzerland--(BUSINESS WIRE)-- Galderma, Nestlé Skin Health’s medical solutions business, today announced positive results from a Phase 2b dose-ranging study of nemolizumab in adult patients with moderate-to-severe atopic dermatitis (AD), a serious, chronic form of eczema. Nemolizumab, an investigational subcutaneous anti-IL-31 receptor A monoclonal antibody, met the primary endpoint of a